Serum hepcidin concentrations and local hepcidin expression have been reported to increase in a variety of neoplasms, including lung cancer, breast cancer, renal carcinoma, prostate cancer, colorectal cancer, and acute leukaemia. The gene discussed is HAMP; the disease is breast cancer.